By Matt Chittock matt.chittocknew@googlemail.com
Publishing: 27 August 2022
Advertising deadline: 12 August 2022
Submissions deadline: 5 August 2022
The flu season is bad news for everyone. Except that is, for suppliers of winter remedies. And, as predicted, the loosening of pandemic restrictions over the past year has been a good thing for the category. As people mixed, they once again had to deal with the various sniffles that come with socialising, pushing up the sales of various wintry medicines. So can the category consolidate on this growth in the coming year? Are post-pandemic lifestyles proving a help or hindrance? And will trading down against the cost of living crisis force it back into value decline?
Sniffling again: Judging by the soaring sales of decongestants, lozenges, and other treatments, coughs and colds returned over the past winter. But which segments grew the most strongly, and why?
Brands: Many of the leading brands more than doubled their sales in the last year. So what did the biggest winners do to differentiate themselves?
Living costs: Like most categories in grocery, rising living costs are expected to lead to down trading in winter remedies. Which products are best placed to capitalise on this? And what can pricier brands do to maintain sales?
No comments yet